Show simple item record

2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

dc.contributor.authorViktória Nagy
dc.contributor.authorHedvig Takács
dc.contributor.authorÁrpád Kormányos
dc.contributor.authorRóbert Sepp
dc.contributor.otherSzegedi Tudományegyetem, Szent-Györgyi Albert Klinikai Központ, Általános Orvostudományi Kar, Kardiológiai Centrum, Szeged
dc.contributor.otherSzegedi Tudományegyetem, Szent-Györgyi Albert Klinikai Központ, Általános Orvostudományi Kar, Kardiológiai Centrum, Szeged
dc.contributor.otherSzegedi Tudományegyetem, Szent-Györgyi Albert Klinikai Központ, Általános Orvostudományi Kar, Kardiológiai Centrum, Szeged
dc.contributor.otherSzegedi Tudományegyetem, Szent-Györgyi Albert Klinikai Központ, Általános Orvostudományi Kar, Kardiológiai Centrum, Szeged
dc.date.accessioned2024-10-02T11:54:06Z
dc.date.available2025-10-02T04:15:42Z
dc.date.issued01-08-2024
dc.identifier.issn-
dc.identifier.urihttps://cardiologia.hungarica.eu/archive/2024-issues/2024-4-contents/2023-focused-update-of-the-2021-esc-guidelines-for-the-diagnosis-and-treatment-of-acute-and-chronic-heart-failure?article=open
dc.description.abstractSince the publication of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure (HF), results of several randomized controlled clinical trials have been published that have a direct impact on day-to-day clinical practice in the treatment of HF patients. These studies provided knowledge that made it necessary to update recommendations for the treatment of HF patients before the publication of the next planned full guideline. Based on the above, the 2023 focused update addresses changes warranted by new evidence in the original guideline's recommendations for addressing the HF. The recommendations for the following sections of the 2021 ESC HF Guideline have been updated: 1) chronic HF: HF with mildly reduced ejection fraction (HFmrEF) and preserved ejection fraction (HFpEF); 2) acute HF; 3) comorbidities and prevention of HF. This article details the updated recommendations and the results of the studies that underpinned the updated recommendations.
dc.format-
dc.language.isoEN
dc.publisherPromenade Kft
dc.relation.uri['https://www.sciencedirect.com/journal/international-journal-of-nursing-sciences', 'https://www.sciencedirect.com/journal/international-journal-of-nursing-sciences/publish/guide-for-authors', 'https://www.elsevier.com/authors/open-access/choice#waivers']
dc.rights['CC BY', 'CC BY-NC-ND']
dc.subject['nursing', 'health care', 'nurses', 'nursing education', 'Nursing', 'RT1-120']
dc.subject.lccSpecialties of internal medicine
dc.title2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
dc.typeArticle
dc.description.keywordsacute and chronic heart failure
dc.description.keywordssglt2 inhibitors
dc.description.keywordstype 2 diabetes mellitus
dc.description.keywordsiron deficiency
dc.description.pages286-293
dc.description.doi10.26430/CHUNGARICA.2024.54.4.286
dc.title.journalCardiologia Hungarica
dc.identifier.e-issn1588-0230
dc.identifier.oaioai:doaj.org/journal:98c017874e234ee6a567f280ee3d223b
dc.journal.infoVolume 54, Issue 4


This item appears in the following Collection(s)

Show simple item record